Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FYN91
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,503
Award facts
- Contract value 100% obligated
- $18,502.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $18,502.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract was awarded on April 24, 2025, with an ultimate completion date of May 15, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026, positioning the contractor as a critical supplier within the federal pharmaceutical supply chain.
DMS Pharmaceutical Group will perform the work at its facility in Park Ridge, Illinois, delivering the pharmaceutical product to support medical supply needs of Department of Defense healthcare facilities. The SPE2DB indefinite delivery contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables. As an established federal contractor registered in SAM.gov since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in fulfilling pharmaceutical requirements for military health facilities nationwide, with a robust portfolio of prior awards covering diverse medical products spanning oncology treatments, vaccines, and specialty pharmaceuticals.
Quick answers
Who was awarded contract SPE2DB25FYN91?
SPE2DB25FYN91 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FYN91 worth?
The government has obligated $18,503 on SPE2DB25FYN91.
Is contract SPE2DB25FYN91 an order under another contract?
Yes. SPE2DB25FYN91 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYN91 competed?
The extent of competition for SPE2DB25FYN91 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award